ResearcherKochi Health Sciences CenterActive in the last 2 years
Jun Iwata
Matched on OpenAlex author ID A5025688662, A5110557492. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 8
- Does Recurrent Pancreatic Cancer Have Similar Outcomes Compared With Primary Metastatic Pancreatic Cancer? Co-author DOI 10.1002/jso.70222↗
- Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. Co-author DOI 10.3390/jcm11226792↗
- A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. Co-author DOI 10.1007/s00423-021-02167-z↗
- Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreatic cancer patients. Co-author DOI 10.1016/j.amjsurg.2019.04.014↗
- A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer. Co-author DOI 10.1245/s10434-018-6485-7↗
- Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer. Co-author DOI 10.1259/bjr.20170165↗
- Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion. Co-author DOI 10.1007/s00423-015-1305-z↗
- Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature. Last author DOI 10.1007/s00423-015-1355-2↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Takehiro Okabayashi · 8 shared papers, 2015–2026 · strength 0.95
- Paper Does Recurrent Pancreatic Cancer Have Similar Outcomes Compared With Primary Metastatic Pancreatic Cancer? DOI 10.1002/jso.70222↗
- Paper Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. DOI 10.3390/jcm11226792↗
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014↗
- Tatsuo Iiyama · 6 shared papers, 2015–2026 · strength 0.76
- Paper Does Recurrent Pancreatic Cancer Have Similar Outcomes Compared With Primary Metastatic Pancreatic Cancer? DOI 10.1002/jso.70222↗
- Paper Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. DOI 10.3390/jcm11226792↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z↗
- Yasuhiro Shimada · 5 shared papers, 2017–2022 · strength 0.56
- Paper Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. DOI 10.3390/jcm11226792↗
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z↗
- Kenta Sui · 5 shared papers, 2017–2022 · strength 0.56
- Paper Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer. DOI 10.3390/jcm11226792↗
- Paper Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreat… DOI 10.1016/j.amjsurg.2019.04.014↗
- Paper A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma. DOI 10.1007/s00423-021-02167-z↗
- Manabu Matsumoto · 3 shared papers, 2015–2026 · strength 0.40
- Paper Does Recurrent Pancreatic Cancer Have Similar Outcomes Compared With Primary Metastatic Pancreatic Cancer? DOI 10.1002/jso.70222↗
- Paper Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cance… DOI 10.1259/bjr.20170165↗
- Paper Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portospleno… DOI 10.1007/s00423-015-1305-z↗
- Sunao Uemura · 1 shared paper, 2026 · strength 0.29
- Shinya Sakamoto · 1 shared paper, 2026 · strength 0.29
- Shuta Tamura · 1 shared paper, 2026 · strength 0.29
- Takatsugu Matsumoto · 2 shared papers, 2020–2021 · strength 0.27
- Yasuo Shima · 4 shared papers, 2015–2018 · strength 0.24
- Paper A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer. DOI 10.1245/s10434-018-6485-7↗
- Paper Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cance… DOI 10.1259/bjr.20170165↗
- Paper Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of … DOI 10.1007/s00423-015-1355-2↗
- Tatsuaki Sumiyoshi · 4 shared papers, 2015–2018 · strength 0.24
- Paper A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer. DOI 10.1245/s10434-018-6485-7↗
- Paper Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cance… DOI 10.1259/bjr.20170165↗
- Paper Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of … DOI 10.1007/s00423-015-1355-2↗
- Toshiyoshi Fujiwara · 1 shared paper, 2022 · strength 0.15
- Keiichi Kubota · 1 shared paper, 2021 · strength 0.13
- Akihito Nishioka · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.